Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter, adding:
“It is live now …4th ESMO webinar of the Precision Oncology series: Genomics Guided Care and Taxonomy of Tumour Agnostic therapeutics.”
Quoting Diogo Martins Branco’s post:
“Now onto the 4th ESMO webinar of the Precision Oncology series: Genomics Guided Care and Taxonomy of Tumour Agnostic therapeutics. Co-chaired by Ben Westphalen and George Pentheroudakis, featuring Claudia Cardone, Vivek Subbiah and Sewanti Limaye.”
Source: Vivek Subbiah/X and Diogo Martins Branco/X
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center. Dr. Vivek Subbiah has served as the principal investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and practice-changing studies that directly led to approvals from the FDA, European Medicines Agency, and other agencies across the world. He is an expert in tumor agnostic precision oncology and leads the BRAF and RET tissue agnostic studies to FDA approval.
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023